Myeloprotection With Trilaciclib in Pan-cancer Population

NCT06297811 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Breast Cancer
Endometrial Cancer
Cervical Cancer
Head And Neck Squamous Cell Carcinomas

Interventions

DRUG: Trilaciclib Injection
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Sun Yat-sen University